Bioavailability and cytosolic kinases modulate response to deoxynucleoside therapy in TK2 deficiency
about
Bioavailability and cytosolic kinases modulate response to deoxynucleoside therapy in TK2 deficiency
description
2019 nî lūn-bûn
@nan
2019年の論文
@ja
2019年学术文章
@wuu
2019年学术文章
@zh
2019年学术文章
@zh-cn
2019年学术文章
@zh-hans
2019年学术文章
@zh-my
2019年学术文章
@zh-sg
2019年學術文章
@yue
2019年學術文章
@zh-hant
name
Bioavailability and cytosolic ...... side therapy in TK2 deficiency
@en
type
label
Bioavailability and cytosolic ...... side therapy in TK2 deficiency
@en
prefLabel
Bioavailability and cytosolic ...... side therapy in TK2 deficiency
@en
P2093
P50
P1433
P1476
Bioavailability and cytosolic ...... side therapy in TK2 deficiency
@en
P2093
Carlos Sierra
Hasan O Akman
Henly Hewan
Kurenai Tanji
Marti Juanola-Falgarona
Michio Hirano
Saba Tadesse
P304
P356
10.1016/J.EBIOM.2019.07.037
P577
2019-08-02T00:00:00Z